T-type calcium channels are involved in hypoxic pulmonary hypertension
Open Access
- 11 July 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 103 (4) , 597-606
Abstract
Pulmonary hypertension (PH) is the main disease of pulmonary circulation. Alteration in calcium homeostasis in pulmonary artery smooth muscle cells (PASMCs) is recognized as a key feature in PH. The present study was undertaken to investigate the involvement of T-type voltage-gated calcium channels (T-VGCCs) in the control of the pulmonary vascular tone and thereby in the development of PH. Experiments were conducted in animals (rats and mice) kept 3–4 weeks in either normal (normoxic) or hypoxic environment (hypobaric chamber) to induce chronic hypoxia (CH) PH. In vivo, chronic treatment of CH rats with the T-VGCC blocker, TTA-A2, prevented PH and the associated vascular hyperreactivity, pulmonary arterial remodelling, and right cardiac hypertrophy. Deletion of the Cav3.1 gene (a T-VGCC isoform) protected mice from CH-PH. In vitro, patch-clamp and PCR experiments revealed the presence of T-VGCCs (mainly Cav3.1 and Cav3.2) in PASMCs. Mibefradil, NNC550396, and TTA-A2 inhibited, in a concentration-dependent manner, T-VGCC current, KCl-induced contraction, and PASMC proliferation. The present study demonstrates that T-VGCCs contribute to intrapulmonary vascular reactivity and is implicated in the development of hypoxic PH. Specific blockers of T-VGCCs may thus prove useful for the therapeutic management of PH.Keywords
This publication has 43 references indexed in Scilit:
- Update in Pulmonary Vascular Diseases 2011American Journal of Respiratory and Critical Care Medicine, 2012
- New mechanisms of pulmonary arterial hypertension: role of Ca2+signalingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertensionRespiratory Research, 2011
- Treatment of pulmonary arterial hypertension with targeted therapiesNature Reviews Cardiology, 2011
- Functional Ion Channels in Human Pulmonary Artery Smooth Muscle Cells: Voltage‐Dependent Cation ChannelsPulmonary Circulation, 2011
- Expression and Physiological Roles of TRP Channels in Smooth Muscle Cells2010
- Heterogeneity of L- and T-Channels in the VasculatureHypertension, 2009
- Smooth muscle cell calcium activation mechanismsThe Journal of Physiology, 2008
- Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertensionProceedings of the National Academy of Sciences, 2003
- Molecular Physiology of Low-Voltage-Activated T-type Calcium ChannelsPhysiological Reviews, 2003